On (b)(6) 2020, a 3/2 amplatzer piccolo occluder was selected for implant in a (b)(6) week old, (b)(6) g patient with the following patent ductus arteriosus(pda) dimensions of: 1.6mm at the pa end of the duct and a length of 10mm.During the procedure the device was placed intraductal, but the device initially pulled through the duct while attempting to place it, so the duct was recrossed and the physician attempted to place the device again.After multiple attempts at repositioning the device, the physician was able to get the device in what was deemed to be a good position.The physician noticed that the device initially moved after being released, so the physician watched it for a couple of minutes, but the device ultimately embolized into the left pulmonary artery (lpa) within a few minutes of releasing it.The physician was able to quickly remove the device with minimal difficulty using a 5mm gooseneck snare and a 4fr cook flexor sheath.The decision the was made to attempt closure with a 4/2 amplatzer piccolo occluder.After repositioning this device in the duct a couple of times, the physician was able to get the device in a good position within the duct.However, echo interrogation and angio through the delivery system revealed comprised lpa flow.Ultimately, the 4/2 device was not released from the cable and was subsequently removed from the patient.The decision was made to stop the procedure at this time and re-evaluate after the baby recovered.The tricuspid valve was thoroughly interrogated with echo, but appeared to be functioning normal at the end of the case.The patient remained stable throughout the procedure and there were no serious adverse events.Both devices were delivered through a 4fr tvlp (lot 7400232).The patient underwent surgical closure of the pda the following day and the patient is currently stable in the nicu.
|
An event of embolism was reported.The investigation confirmed the device met functional and dimensional specifications when analyzed at abbott.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.A review of the measurements as reported from the field was performed.Per the instruction for use, arten600042307 version b, for a pda with a minimum diameter of 1.6 mm and a length of 10mm, a 3/2mm piccolo, the size of the embolized device, is recommended per the sizing table.The cause of the reported incident could not be conclusively determined.A capa was initiated for further investigation on the embolism, per internal procedures.
|